Category Archives: N-Methyl-D-Aspartate Receptors

´╗┐Table 1 Demographic, medical and radiographic characteristics of the four cases at baseline thead th style=”background-color:#0000FF; color:#FFFFFF;” align=”remaining” rowspan=”1″ colspan=”1″ /th th style=”background-color:#0000FF; color:#FFFFFF;” align=”center” rowspan=”1″ colspan=”1″ Case 1 /th th style=”background-color:#0000FF; color:#FFFFFF;” align=”center” rowspan=”1″ colspan=”1″ Case 2 /th th style=”background-color:#0000FF; color:#FFFFFF;” align=”center” rowspan=”1″ colspan=”1″ Case 3 /th th style=”background-color:#0000FF; color:#FFFFFF;” align=”center” rowspan=”1″ colspan=”1″ Case 4 /th /thead Age (years) 37363027 Sex MFMM Age at onset (years) 23281917 Delay in analysis (years) 2130.25 Clinical Data ?????ISH 16.5111520?????BASFI95.83.77.6?????BASDAI64.644.25 Biological and Radiological data ?????ESR,mean (mm)44154378?????CRP, mean( mg/l)49162345?????BASRI hip2322?????Joint space, mean(mm)2.72.22.82AntiTNF alpha treatmentEtanerceptInfliximabEtanerceptEtanerceptDelay between the first and the last radiograph44410 Open in a separate window ISH: mean index of severity for osteoarthritis for the hip, BASFI: Bath Ankylosing Spondylitis Functional index, BASDAI: Bath Ankylosing Spondylitis Activity Index, ESR: Erythrocyte Sedimentation Rate, TNFSF10 CRP: C Reactive Protein, BASRI: Bath Ankylosing Spondylitis Radiographic Index After an average of 5.5 years of treatment with TNF inhibitors,…

Read more

1/1